Medication-Assisted Treatment for Opioid-Use Disorder
Date Added: 
    October 3, 2019
      Journal/Publication: 
    Mayo Clinic Proceedings 
      Publisher: 
    Mayo Foundation for Medical Education and Research / Elsevier Inc.
      Publication Date: 
    September 9, 2019
      Issue: 
    10
      Volume: 
    94
      Pages: 
    2072-2086
      Type: 
    Meta-analyses, Reviews, and Guidelines
      Format: 
    Article
      DOI (1): 
    10.1016/j.mayocp.2019.03.029
      PMID (1): 
    31543255
      Abstract
The United States is in the midst of a national opioid epidemic. Physicians are encouraged both to prevent and treat opioid-use disorders (OUDs). Although there are 3 Food and Drug Administration-approved medications to treat OUD (methadone, buprenorphine, and naltrexone) and there is ample evidence of their efficacy, they are not used as often as they should. We provide a brief review of the 3 primary medications used in the treatment of OUD. Using data from available medical literature, we synthesize existing knowledge and provide a framework for how to determine the optimal approach for outpatient management of OUD with medication-assisted treatments.
Text Availability
Free full text
      
          
RPR Commentary
A nice review of how and when to use the three available medications for treating patients with opioid dependency. James W. Mold, MD, MPH